The number of metabolic syndrome components is a good risk indicator for both early- and late-stage kidney damage

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 3, 2014, Pages 277-285

  Okada, R ^a   Yasuda, Y ^a   Tsushita, K ^b   Wakai, K ^a   Hamajima, N ^a   Matsuo, S ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Aichi Health Promotion Foundation   (Japan)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Metabolic syndrome; Prediabetes; Prehypertension; Renal hyperfiltration

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; RISK FACTOR;

CHRONIC KIDNEY DISEASE; GLOMERULAR FILTRATION RATE; METABOLIC SYNDROME; PREDIABETES; PREHYPERTENSION; RENAL HYPERFILTRATION;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84895828562     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.08.004     Document Type: Article

References (39)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International association for the study of obesity. Circulation 2009, 120:1640-1645.
2. Thomas G., Sehgal A.R., Kashyap S.R., Srinivas T.R., Kirwan J.P., Navaneethan S.D. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011, 6:2364-2373.
3. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140:167-174.
4. Tesauro M., Canale M.P., Rodia G., Di Daniele N., Lauro D., Scuteri A., et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract 2011 Mar 7, 2011:653182.
5. So W.Y., Kong A.P., Ma R.C., Ozaki R., Szeto C.C., Chan N.N., et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006, 29:2046-2052.
6. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
7. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 2003, 289:2560-2572. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating CommitteeNational High Blood Pressure Education Program Coordinating Committee.
8. Fox C.S., Larson M.G., Leip E.P., Meigs J.B., Wilson P.W., Levy D. Glycemic status and development of kidney disease: the Framingham Heart Study. Diabetes Care 2005, 28:2436-2440.
9. Yano Y., Fujimoto S., Sato Y., Konta T., Iseki K., Moriyama T., et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int 2012, 81:293-299.
10. Muntner P., Coresh J., Smith J.C., Eckfeldt J., Klag M.J. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000, 58:293-301.
11. Cignarelli M., Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis 2007, 17:757-762.
12. Brenner B.M., Lawler E.V., Mackenzie H.S. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996, 49:1774-1777.
13. Ruggenenti P., Porrini E.L., Gaspari F., Motterlini N., Cannata A., Carrara F., for the GFR Study Investigators, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012, 35:2061-2068.
14. Okada R., Yasuda Y., Tsushita K., Wakai K., Hamajima N., Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 2012, 27:1821-1825.
15. Okada R., Wakai K., Naito M., Morita E., Kawai S., Yin G., et al. Renal hyperfiltration in prediabetes confirmed by fasting plasma glucose and hemoglobin A1c. Ren Fail 2012, 34:1084-1090.
16. Melsom T., Mathisen U.D., Ingebretsen O.C., Jenssen T.G., Njølstad I., Solbu M.D., et al. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care 2011, 34:1546-1551.
17. Palatini P. Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Dial Transplant 2012, 27:1708-1714.
18. Wuerzner G., Pruijm M., Maillard M., Bovet P., Renaud C., Burnier M., et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2010, 56:303-312.
19. Tomaszewski M., Charchar F.J., Maric C., McClure J., Crawford L., Grzeszczak W., et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007, 71:816-821.
20. den Boer A.T., Herraets I.J., Stegen J., Roumen C., Corpeleijn E., Schaper N.C., et al. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study. Nutr Metab Cardiovasc Dis 2013, 23:1147-1153.
21. Mizushima S., Tsushita K. New strategy on prevention and control of noncommunicable lifestyle-related diseases focusing on metabolic syndrome in Japan. Asian Perspect Evid Health Promot Educ 2011, 31-39.
22. Ko S.H., Kim S.R., Kim D.J., Oh S.J., Lee H.J., Shim K.H., et al. 2011 clinical practice guidelines for type 2 diabetes in Korea. Diabetes Metab J 2011, 35:431-436. Committee of Clinical Practice Guidelines, Korean Diabetes AssociationKorean Diabetes Association.
23. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992. Collaborators developing the Japanese equation for estimated GFR.
24. Palatini P., Mormino P., Dorigatti F., Santonastaso M., Mos L., De Toni R., et al. Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int 2006, 70:578-584. HARVEST Study Group.
25. Palatini P., Mos L., Ballerini P., Mazzer A., Saladini F., Bortolazzi A., et al. Relationship between GFR and albuminuria in stage 1 hypertension. Clin J Am Soc Nephrol 2013, 8:9-66.
26. Curhan G.C. Prediabetes, prehypertension is it time for pre-CKD?. Clin J Am Soc Nephrol 2010, 5:557-559.
27. American Diabetes Association Standards of medical care in diabetes-2009. Diabetes Care 2009, 32(Suppl. 1):S13-S61.
28. Cheng H.T., Huang J.W., Chiang C.K., Yen C.J., Hung K.Y., Wu K.D. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. Clin Endocrinol Metab 2012, 97:1268-1276.
29. Nerpin E., Risérus U., Ingelsson E., Sundström J., Jobs M., Larsson A., et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 2008, 31:1550-1555.
30. Sesti G., Succurro E., Arturi F., Andreozzi F., Laino I., Perticone M., et al. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutr Metab Cardiovasc Dis 2011, 21:933-940.
31. Chen J., Muntner P., Hamm L.L., Fonseca V., Batuman V., Whelton P.K., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003, 14:469-477.
32. Schinzari F., Tesauro M., Rovella V., Galli A., Mores N., Porzio O., et al. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab 2010, 299:E947-E952.
33. Park J.H., Oh S.W., Ahn S.Y., Kim S., Na K.Y., Chae D.W., et al. Decreased estimated glomerular filtration rate is not directly related to increased insulin resistance. Diabetes Res Clin Pract 2013, 99:366-371.
34. Lorenzo C., Wagenknecht L.E., Hanley A.J., Rewers M.J., Karter A.J., Haffner S.M. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010, 3:2104-2109.
35. Kronenberg F., Kuen E., Ritz E., Junker R., König P., Kraatz G., et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000, 11:105-115.
36. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003, 14:1480-1486.
37. Arnlöv J., Ingelsson E., Sundström J., Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121:230-236.
38. Helal I., Fick-Brosnahan G.M., Reed-Gitomer B., Schrier R.W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012, 8:293-300.
39. Monami M., Pala L., Bardini G., Francesconi P., Cresci B., Marchionni N., et al. Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study. Acta Diabetol 2009, 46:191-196.